Actively Recruiting
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
Led by Latin American Cooperative Oncology Group · Updated on 2025-02-12
150
Participants Needed
10
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a retrospective observational cohort study to evaluate clinical, pathological, and treatment data of people diagnosed with adrenocortical carcinoma since the year 2000. This rare cancer has a notably higher incidence in certain regions of Brazil, partly due to a common genetic mutation called TP53-R337H. The study aims to characterize this patient group and identify factors that influence outcomes, focusing on cases from major Brazilian treatment centers. Participants in this study are identified based on past clinical records rather than receiving new treatments. The study collects data from medical evaluations and follow-ups conducted at reference centers, including initial diagnosis and recurrences from 2000 onward. There are no interventions or experimental treatments given during this observational study. Participants' involvement includes reviewing their medical history and clinical data over approximately 18 months. Researchers will analyze demographic and clinical characteristics from existing records to better understand the disease in this population. The study does not involve active treatment but focuses on data collection and analysis for improved knowledge of adrenocortical carcinoma in Brazil.
CONDITIONS
Brief Title
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants over 18 years old
- Diagnosis of adrenocortical carcinoma with at least one clinical evaluation at the reference institution
- Initial diagnosis or recurrence from the year 2000 onwards
You will not qualify if you...
- Participants with insufficient clinical or pathological data in the medical records
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 18 months
Participants with adrenocortical carcinoma are observed to characterize clinical and epidemiological features over time.
Visits occur as part of routine clinical evaluations
Trial Site Locations
Total: 10 locations
1
Pronutrir - Suporte Nutricional e Quimioterapia
Fortaleza, Ceará, Brazil, 60.810-180
Actively Recruiting
2
Hospital do Câncer do Maranhão Dr. Tarquínio Lopes Filho
São Luís, Maranhão, Brazil, 65.015-460
Actively Recruiting
3
Hospital Erasto Gaertner
Curitiba, Paraná, Brazil, 81.520-060
Actively Recruiting
4
Hospital Santa Joana Recife (Instituto Américas PE)
Recife, Pernambuco, Brazil, 52.011-000
Actively Recruiting
5
UOPECCAN - Hospital do Câncer de Cascavel
Cascavel, Santa Catarina, Brazil, 85.806-300
Actively Recruiting
6
FUNFARME - Hospital de Base de São José do Rio Preto
São José do Rio Preto, São Paulo, Brazil, 15.090-000
Actively Recruiting
7
INCA - Instituto Nacional de Câncer
Rio de Janeiro, Brazil, 20.230-130
Actively Recruiting
8
BP - A Beneficência Portuguesa de São Paulo
São Paulo, Brazil, 01.323-030
Actively Recruiting
9
HAOC - Hospital Alemão Oswaldo Cruz
São Paulo, Brazil, 01.327-001
Actively Recruiting
10
A.C. Camargo Cancer Center
São Paulo, Brazil, 01.509-001
Actively Recruiting
Research Team
G
Giana Blume Corssac
L
Laura Voelcker
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here